Close Menu

NEW YORK (GenomeWeb) — Quidel today announced the pricing of its previously announced underwritten public offering of $150 million in convertible senior notes due 2020.

The notes will pay interest at a rate of 3.25 percent per year, payable semiannually on June 15 and Dec. 15 of each year, beginning on June 15, 2015. The notes will mature on Dec. 15, 2020, unless earlier repurchased by Quidel or converted.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.